1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. SUPERNUS PHARMACEUTICALS INC
Supernus Pharmaceuticals Inc XNAS: SUPN
44.80 0.81 (1.84%)
625.3K
XNAS Volume

XNAS 17 Sep, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Board Meeting
The next board meeting for Supernus Pharmaceuticals Inc is on 18 Sep 2025 for the purpose of TD Cowen's 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit See details

Supernus Pharmaceuticals Inc - SUPN - stock price prediction, stock price target, analyst ratings from 5 analysts

Supernus Pharmaceuticals Inc has a share price target of US$ 44, revenue growth forecast of 4.2%, for FY25, based on top 5 analyst calls.